INVESTOR’S BUSINESS DAILY
This year, the first two straight-up marijuana stocks joined the New York Stock Exchange and the Nasdaq.
Tilray Inc. announced it has launched an IPO of its Class 2 common stock pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission.
Tilray Inc., a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, today
The partnership signals the first deal between a major pharmaceutical company and a Canadian cannabis producer.
THE GLOBE AND MAIL
Tilray has raised $60-million to expand its growing capacity in Canada and Europe and to push its brand of medical cannabis products into a handful of new countries.